Physicians surprised tennis star took banned heart drug

Tim Casey | | Cardiovascular Business | Patient Care

Physicians contacted by Reuters were surprised that tennis star Maria Sharapova took meldonium, a heart drug banned by the International Tennis Federation (ITF). 

The ITF suspended Sharapova after she tested positive for the medication on Jan. 26, the day she lost to Serena Williams at the Australian Open. Sharapova admitted on March 7 that she began taking meldonium 10 years ago because she had irregular electrocardiogram results, a magnesium deficiency and a family history of diabetes, according to Reuters. 

Meldonium is not approved by the FDA or the European Medicines Agency. 

For more on this story, follow the link below:

Experts perplexed over why Sharapova was taking banned heart drug

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."